Safety and Tolerability Clinical Trial of Different Doses of the Immunotherapeutic Drug Mobilan (M-VM3) and Placebo in Patients With Prostate Cancer

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2015
Phase I single-blinded, randomized, placebo-controlled trial evaluating safety, tolerability, pharmacokinetics and pharmacodynamics of single injections of ascending doses of investigational drug product Mobilan (М-VM3) administered directly into the prostate of patients with prostate cancer.
Epistemonikos ID: 7db5bbb57abe264c4a13733482be90f30b5754dd
First added on: Dec 20, 2022